The results of surgical evacuation of spontaneous intracerebral hemato
mas are disappointing. This is largely because experimental studies ha
ve now confirmed that the brain surrounding an intracerebral hematoma
develops profound and extensive ischemia. The volume of this ischemic
brain may exceed the volume of the hemorrhage several times. This has
been demonstrated experimentally using C-14-iodoantipyrene autoradiogr
aphy in various modifications of the intracerebral hemorrhage model. T
hese models have demonstrated that the pathophysiology of the ischemia
is partly due to direct mechanical compression. There is also a compo
nent of the ischemic process induced by vasoconstrictor substances in
blood. The diffuse uncontained type of hemorrhage (subarachnoid or int
raventricular) causes a global reduction in cerebral perfusion pressur
e. The focal ischemic event is initiated at the time of hemorrhage and
is largely irreversible. The experimental evidence to date indicates
that neuroprotective agents (calcium channel blockers and N-methyl-D-a
spartate receptor antagonists) reduce ischemic brain damage. Similarly
, in immunosuppressed animals the amount of brain edema that follows t
he initial ischemic insult was reduced. These studies indicate that ph
armacological neuroprotective strategies can minimize the brain damage
that follows intracerebral hemorrhage. Early removal of the mass lesi
on may play a role, but it is unlikely to reverse the ischemic process
if it is the only treatment offered.